SCHEMBL24625817

SCHEMBL24625817

Cc1ccc(Cn2c3ccccc3c3ccccc32)c(C)c1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 1/20 0.48
▸ CYP1A2 P05177 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ CHRNE Q04844 1/20 0.44
▸ KDM4A O75164 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ P2RX4 Q99571 2/20 0.42
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ GLA P06280 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ APEX1 P27695 1/20 0.40
▸ SYK P43405 1/20 0.40
▸ RECQL P46063 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ THRB P10828 1/20 0.40
▸ ALDH1A1 P00352 2/20 0.39
▸ USP2 O75604 1/20 0.39
▸ BACE1 P56817 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21154987 0.85 CYP19A1 (0.44) CYP19A1CYP1A2CYP2C19CHRNEKDM4A
SCHEMBL14492825 0.79 CYP19A1 (0.53) CYP19A1CYP1A2CYP2C19CHRNEKDM4A
SCHEMBL29093444 0.79 CHRNE (0.63) CYP19A1CYP1A2CYP2C19CHRNEKDM4A
SCHEMBL30616063 0.79 CHRNE (0.63) CYP19A1CYP1A2CYP2C19CHRNEKDM4A
SCHEMBL14492829 0.78 CYP19A1 (0.61) CYP19A1CYP1A2CYP2C19P2RX4ALDH1A1
SCHEMBL24984732 0.77 TNF (0.54) CYP19A1CYP1A2CYP2C19CHRNEKDM4A
SCHEMBL19793268 0.76 CHRNE (0.43) CYP19A1CYP1A2CYP2C19CHRNEKDM4A
SCHEMBL14492832 0.72 CYP19A1 (0.59) CYP19A1CYP1A2CYP2C19CHRNELMNA
SCHEMBL20016296 0.72 CYP19A1 (0.53) CYP19A1CYP1A2CYP2C19CHRNEP2RX4
SCHEMBL18406152 0.71 CHRNE (0.42) CYP19A1CYP1A2CYP2C19CHRNEKDM4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230217805-A1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-06 — — US disclosed
US-20220223804-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-07-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230217805-A1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE C1S, C5, CCNT1 CYP19A1 1224/4885CYP1A2 437/4885CYP2C19 903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback